Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 57,063 | 48,868 | 43,562 | 35,578 | 30,475 |
| Cost of Goods | 3,562 | 2,153 | 2,455 | 2,135 | 2,224 |
| Gross Profit | 53,501 | 46,715 | 41,107 | 33,443 | 28,251 |
| Operating Expenses | 118,142 | 101,687 | 111,571 | 99,222 | 96,511 |
| Operating Income | -64,079 | -54,819 | -70,009 | -65,644 | -68,036 |
| Other Income | 1,032 | 1,170 | 1,107 | 1,063 | 993 |
| Pre-tax Income | -63,047 | -53,649 | -68,902 | -64,581 | -67,043 |
| Income Tax | 219 | 647 | -31 | 667 | 398 |
| Net Income Continuous | -63,266 | -54,296 | -68,871 | -65,248 | -67,441 |
| Net Income | $-63,266 | $-54,296 | $-68,871 | $-65,248 | $-67,441 |
| EPS Basic Total Ops | -0.51 | -0.44 | -0.56 | -0.53 | -0.55 |
| EPS Basic Continuous Ops | -0.51 | -0.44 | -0.55 | -0.53 | -0.55 |
| EPS Diluted Total Ops | -0.51 | -0.44 | -0.56 | -0.53 | -0.55 |
| EPS Diluted Continuous Ops | -0.51 | -0.44 | -0.55 | -0.53 | -0.55 |
| EBITDA(a) | $-63,434 | $-54,233 | $-69,461 | $-64,788 | $-67,544 |